General MedicationsORALGeneric
ELIXICON
THEOPHYLLINE
Standard Dose
100MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview ELIXICON is listed in Drugs@FDA under application 085502 (ANDA).
Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength SUSPENSION;ORAL - 100MG/5ML Sponsor FOREST LABS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview ELIXICON is listed in Drugs@FDA under application 085502 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength SUSPENSION;ORAL - 100MG/5ML Sponsor FOREST LABS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.